Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04155 (
pS2
)
1,234
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Secreted growth factors have been shown to stimulate the transcriptional activity of estrogen receptors (ER) that are responsible for many biological processes. However, whether these growth factors physically interact with ER remains unclear. Here, we show for the first time that
connective tissue growth factor
(
CTGF
) physically and functionally associates with ER.
CTGF
interacted with ER both in vitro and in vivo.
CTGF
interacted with ER DNA-binding domain. ER interaction region in
CTGF
was mapped to the thrombospondin type I repeat, a cell attachment motif. Overexpression of
CTGF
inhibited ER transcriptional activity as well as the expression of estrogen-responsive genes, including
pS2
and cathepsin D. Reduction of endogenous
CTGF
with
CTGF
small interfering RNA enhanced ER transcriptional activity. The interaction between
CTGF
and ER is required for the repression of estrogen-responsive transcription by
CTGF
. Moreover,
CTGF
reduced ER protein expression, whereas the
CTGF
mutant that did not repress ER transcriptional activity also did not alter ER protein levels. The results suggested the transcriptional regulation of estrogen signaling through interaction between
CTGF
and ER, and thus may provide a novel mechanism by which cross-talk between secreted growth factor and ER signaling pathways occurs.
...
PMID:Suppression of estrogen receptor transcriptional activity by connective tissue growth factor. 2162 92